THERAPTEN BIOSCIENCES
TheraPten is a Canadian preclinical biotechnology company. The company has collaborated with the Canadian National Research Council for its preclinical studies. TheraPten’s concept is simple and straightforward: put back a naturally occurring tumor suppressor to those cancer patients who lost it.
THERAPTEN BIOSCIENCES
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2016-01-01
Address:
Kelowna, British Columbia, Canada
Country:
Canada
Website Url:
http://www.therapten.com
Total Employee:
11+
Status:
Active
Contact:
(250) 864-2740
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SPF Google Apps For Business Sectigo SSL Sectigo Domain SSL LiteSpeed Parallels Plesk Panel
More informations about "TheraPten Biosciences"
TheraPten BioSciences Inc
TheraPten is a Canadian preclinical biotechnology company. The company has collaborated with the Canadian National Research Council for its preclinical studies. TheraPten’s concept is …See details»
TheraPten Biosciences - Crunchbase Company Profile & Funding
TheraPten is a Canadian preclinical biotechnology company. The company has collaborated with the Canadian National Research Council for its preclinical studies. TheraPten’s concept is …See details»
TheraPten Biosciences Inc. | Canada Corporation Directory
TheraPten Biosciences Inc. is a Non-distributing corporation with 50 or fewer shareholders corporation type, which located at 800 - 885 West Georgia Street Vancouver BC V6C 3H1 …See details»
TheraPten Biosciences Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TheraPten Biosciences Inc of Kelowna, BC. Get the latest business insights from Dun & Bradstreet.See details»
TheraPten Biosciences Company Profile 2024: Valuation, Funding ...
TheraPten Biosciences is headquartered in Kelowna, Canada. What is the size of TheraPten Biosciences? TheraPten Biosciences has 2 total employees. What industry is TheraPten …See details»
TheraPten Biosciences Inc - Org Chart, Teams, Culture & Jobs
TheraPten is a Canadian preclinical biotechnology company. The company has collaborated with the Canadian National Research Council for its preclinical studies. TheraPten’s concept is …See details»
TheraPten Biosciences Inc - LinkedIn
TheraPten is a Canadian preclinical biotechnology company. TheraPten’s concept is simple and straightforward: put back a naturally occurring tumor suppressor to those cancer patients who …See details»
TheraPten - Company Profile - Tracxn
TheraPten - Developing PTEN-L, a natural human anti-cancer tumour suppressor protein, as an injectable biological therapy.. Raised a total funding of $2M over 2 rounds. Founded by …See details»
TheraPten BioSciences - Overview, News & Similar companies
TheraPten is a Canadian preclinical biotechnology company. The company has collaborated with the Canadian National Research Council for its preclin ical studies. TheraPten's concept is …See details»
TheraPten Biosciences - Funding, Financials, Valuation & Investors
Jun 25, 2018 TheraPten Biosciences is a Canadian preclinical biotechnology company. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …See details»
TheraPten Biosciences - Products, Competitors, Financials, …
TheraPten is a Canadian biotech company developing PTEN-L, the world's first natural human anti-cancer tumor suppressor protein, as an injectable biological therapy. Use the CB Insights …See details»
TheraPten Biosciences - VentureRadar
TheraPten is a Canadian biotech company developing injectable biological therapies to replace missing human tumor suppressors. Tumor suppressors are the body’s prime defense against …See details»
TheraPten BioSciences Enters Exclusive Licensing Agreement With ...
TheraPten Biosciences Inc., a Canadian biotechnology company, has entered into an exclusive licensing agreement with Columbia University on two globally issued patent families covering …See details»
TheraPten Biosciences - Tech Stack, Apps, Patents & Trademarks
Organization. TheraPten Biosciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 2. About. …See details»
CN114127122 - Drug Targets, Indications, Patents - Synapse
CN114127122, Initially developed by TheraPten Biosciences, Inc., Now, its global highest R&D status is Discovery, Therapeutic Areas: Neoplasms,Infectious Diseases ...See details»
TheraPten BioSciences Inc
PIPELINE. The PR61 program (LNP expressing cell-permeable PTEN) is progressing toward clinical trials. The PR93 program (LNP expressing cell-permeable PTEN) is progressing …See details»
TheraPten Biosciences Reviews | Read Client Reviews of TheraPten ...
Read reviews of TheraPten Biosciences. Write and share your personal story. Your experience will help others make the right buying decision. Trustburn. Categories Log in For business. …See details»
PR-93 - Drug Targets, Indications, Patents - Synapse - Patsnap
PR-93, Initially developed by TheraPten Biosciences, Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Neoplasms, Active Indication ...See details»
TheraPten BioSciences Inc
In August 2021, TheraPten obtained a US patent covering the PR61 cDNA & protein with broad Composition of Matter claims. Projected expiry is in 2040, excluding SPC and data exclusivity …See details»
Agreement with Oblates hailed as major step in shining light on ...
1 day ago An agreement years in the making is being called "a significant step" in the ongoing push for transparency by confronting the difficult truths surrounding a dark part of Canada's past.See details»